Polymorphisms in the human HL gene contribute to susceptibility to cardiovascular disease, although its effect can be modulated by other lipid abnormalities or polymorphisms in other genes involved in lipoprotein metabolism [11]–[13]. This evidence concerns the gene LIPC and cardiovascular disorder.